BACKGROUND: High-flow oxygen therapy through nasal cannula (HFNC) could reduce intubation rate and mortality rate among patients with acute respiratory failure. We evaluated the physiological responses and clinical outcomes of HFNC in patients with acute heart failure (AHF). METHODS: A retrospective cohort analysis was performed in single medical tertiary center. Patients with AHF who had a progressive hypoxemia after oxygenation via facemask were divided into intubation group and HFNC group. We analyzed the physiological responses and in-hospital clinical outcomes between two groups. RESULTS: Seventy-three patients of intubation group and 76 patients of HFNC group were included. Baseline characteristics were well-balanced between two groups. There were no differences in changes of mean arterial pressure, heart rate, and pulse oxygen saturation during the first 6 hours. Among HFNC group, 66 of 76 patients (86.8%) were successfully recovered from progressive hypoxemia without endotracheal intubation, and there were no differences in in-hospital clinical outcomes between two groups. CONCLUSIONS: This study showed HFNC group had a similar result of improvement of oxygen saturation and in-hospital clinical outcomes compared with intubation group in AHF. Present study supported HFNC could be considered as initial choice of oxygen therapy in selected patients of AHF.
BACKGROUND: High-flow oxygen therapy through nasal cannula (HFNC) could reduce intubation rate and mortality rate among patients with acute respiratory failure. We evaluated the physiological responses and clinical outcomes of HFNC in patients with acute heart failure (AHF). METHODS: A retrospective cohort analysis was performed in single medical tertiary center. Patients with AHF who had a progressive hypoxemia after oxygenation via facemask were divided into intubation group and HFNC group. We analyzed the physiological responses and in-hospital clinical outcomes between two groups. RESULTS: Seventy-three patients of intubation group and 76 patients of HFNC group were included. Baseline characteristics were well-balanced between two groups. There were no differences in changes of mean arterial pressure, heart rate, and pulse oxygen saturation during the first 6 hours. Among HFNC group, 66 of 76 patients (86.8%) were successfully recovered from progressive hypoxemia without endotracheal intubation, and there were no differences in in-hospital clinical outcomes between two groups. CONCLUSIONS: This study showed HFNC group had a similar result of improvement of oxygen saturation and in-hospital clinical outcomes compared with intubation group in AHF. Present study supported HFNC could be considered as initial choice of oxygen therapy in selected patients of AHF.
Authors: J Masip; A J Betbesé; J Páez; F Vecilla; R Cañizares; J Padró; M A Paz; J de Otero; J Ballús Journal: Lancet Date: 2000 Dec 23-30 Impact factor: 79.321
Authors: John Victor Peter; John L Moran; Jennie Phillips-Hughes; Petra Graham; Andrew D Bersten Journal: Lancet Date: 2006-04-08 Impact factor: 79.321
Authors: Marcelo Park; Marcia C Sangean; Marcia de S Volpe; Maria I Z Feltrim; Emilia Nozawa; Paulo F Leite; Marcelo B Passos Amato; Geraldo Lorenzi-Filho Journal: Crit Care Med Date: 2004-12 Impact factor: 7.598
Authors: Jens Spiesshoefer; Britta Bannwitz; Michael Mohr; Simon Herkenrath; Winfried Randerath; Paolo Sciarrone; Christian Thiedemann; Hartmut Schneider; Andrew T Braun; Michele Emdin; Claudio Passino; Michael Dreher; Matthias Boentert; Alberto Giannoni Journal: Sleep Breath Date: 2020-08-22 Impact factor: 2.816
Authors: Yue Yu; Ren-Qi Yao; Yu-Feng Zhang; Su-Yu Wang; Wang Xi; Jun-Nan Wang; Xiao-Yi Huang; Yong-Ming Yao; Zhi-Nong Wang Journal: Mil Med Res Date: 2021-07-09